New fat-burning diabetes pill protects muscle and appetite

Researchers have developed a new oral drug that boosts metabolic activity in muscle rather than altering appetite like GLP-1 drugs. Early trials suggest it improves blood sugar control and fat metabolism while preserving muscle mass, with fewer side effects. Because it acts through a different mechanism, it could be paired with GLP-1 treatments for even […]

Fight Aging! Newsletter, December 8th 2025

Fight Aging! publishes news and commentary relevant to the goal of ending all age-related disease, to be achieved by bringing the mechanisms of aging under the control of modern medicine. This weekly newsletter is sent to thousands of interested subscribers. To subscribe to the newsletter, please visit: https://www.fightaging.org/newsletter/. To unsubscribe, send email or reply to […]

Star UK chef redesigns menu for dieters on skinny jabs

Chef Heston Blumenthal poses for a portrait outside The Fat Duck restaurant in Bray, west of London. (AFP pic) LONDON: When Michelin-starred UK chef Heston Blumenthal turned to skinny jabs to lose weight, his appetite evaporated and he realised the popularity of such medications risked biting into restaurant sales. So he devised a menu-lite, offering […]

Obesity_Presentation_50_Slides by qasim.pptx

Obesity is multifactorial. Causes serious complications. Managed by diet + exercise + counseling. Drugs (GLP-1 agonists) are effective. Bariatric surgery for selected patients. Prevention through lifestyle + public health.

“Paw-zempic”: Could GLP-1 drugs work for obese cats?

Weight loss drugs for Americans have skyrocketed to success. Now, the GLP-1 frenzy could be heading to a new frontier: your pets. A San Francisco biopharmaceutical company says it is conducting a pilot study on a GLP-1 drug for cats with obesity. OKAVA CEO Michael Klotsman joins CBS News to discuss.